{"id":237726,"date":"2024-04-17T17:04:41","date_gmt":"2024-04-17T15:04:41","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=237726"},"modified":"2024-05-09T10:55:33","modified_gmt":"2024-05-09T08:55:33","slug":"estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/","title":{"rendered":"Un estudi liderat pel CSIC troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 enfront del SARS-CoV-2"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">La uni\u00f3 de ribavirina i remdesivir elimina el virus en induir un exc\u00e9s de mutacions en el seu genoma que li impedeixen multiplicar-se<\/h2>\n\n\n\n<p>Un estudi liderat per cient\u00edfics del <strong>Consell Superior d&#8217;Investigacions Cient\u00edfiques<\/strong> (CSIC) ha descobert que una <strong>combinaci\u00f3 de dos f\u00e0rmacs<\/strong>, ribavirina i remdesivir, \u00e9s efectiva <strong>contra el virus responsable de la SARS-CoV-2<\/strong>. Aquesta combinaci\u00f3 <strong>elimina r\u00e0pidament el virus<\/strong>, oferint <strong>noves perspectives de tractament<\/strong>, especialment per a pacients vulnerables. La investigadora Celia Perales destaca la import\u00e0ncia de trobar noves combinacions de f\u00e0rmacs per a combatre el virus, especialment en <strong>pacients immunodeprimits<\/strong>.\u00a0<\/p>\n\n\n\n<p>Els cient\u00edfics van utilitzar seq\u00fcenciaci\u00f3 massiva per a entendre com funcionen aquests f\u00e0rmacs. Esteban Domingo assenyala que els f\u00e0rmacs provoquen un <strong>exc\u00e9s de mutacions en el genoma del virus<\/strong>, la qual cosa<strong> inhibeix la seva replicaci\u00f3<\/strong>, un proc\u00e9s conegut com &#8220;<strong>mutag\u00e8nesis letal<\/strong>&#8220;. Aquest mecanisme \u00e9s una<strong> estrat\u00e8gia antiviral efectiva <\/strong>que ja s&#8217;ha usat amb \u00e8xit en altres virus ARN.<\/p>\n\n\n\n<p>El treball \u00e9s el resultat de la <strong>col\u00b7laboraci\u00f3 entre diversos centres del CSIC<\/strong>. A m\u00e9s, la col\u00b7laboraci\u00f3 amb l&#8217;Institut de Recerca Sanit\u00e0ria Fundaci\u00f3 Jim\u00e9nez D\u00edaz obre la possibilitat de <strong>portar aquestes troballes a la pr\u00e0ctica cl\u00ednica<\/strong>.<\/p>\n\n\n\n<p>Podeu llegir el comunicat sobre la combinaci\u00f3 de f\u00e0rmacs per SARS-CoV-2 complet <a href=\"https:\/\/www.csic.es\/es\/actualidad-del-csic\/un-estudio-liderado-por-el-csic-halla-una-combinacion-de-farmacos-eficaz-frente-al-sars-cov-2\">aqu\u00ed<\/a>.<\/p>\n\n\n\n<p>Font i imatge: CSIC<strong><em><span style=\"text-decoration: underline\"><\/span><\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un estudi liderat per cient\u00edfics del Consell Superior de Recerques Cient\u00edfiques (CSIC) ha descobert que una combinaci\u00f3 de dos f\u00e0rmacs, ribavirina i remdesivir, \u00e9s efectiva contra el virus responsable de la COVID-19.<\/p>\n","protected":false},"author":5,"featured_media":237729,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"<!-- wp:heading {\"textColor\":\"vivid-red\"} -->\n<h2 class=\"wp-block-heading has-vivid-red-color has-text-color\">Qualsevol treballador del sector pot adherir-se lliurement a aquest acord perqu\u00e8 li sigui aplicat l\u2019augment salarial retroactiu de 2023 (4%) i la resta de condicions contemplades a l\u2019acord<\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p><br>El dimarts, 6 de febrer, es va signar un <strong>acord retributiu-salarial i de tancament de 2023 entre l'AFB<\/strong> (Associaci\u00f3 de Farm\u00e0cies de Barcelona) i els <strong>sindicats <\/strong>UGT de Catalunya, CCOO de Catalunya i ASATEF (Associaci\u00f3 Sindical d'Auxiliars, T\u00e8cnics i Empleats de Farm\u00e0cia de Barcelona).<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>A l'esmentat acord entre l'empresarial i les <strong>organitzacions sindicals que representen pr\u00e0cticament el 75%<\/strong> dels 11.200 emprats\/es en les farm\u00e0cies de la prov\u00edncia de Barcelona, <strong>no es va sumar AFASCAT<\/strong> (l'Associaci\u00f3 de Farmac\u00e8utics\/es Substituts\/es de Catalunya).<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>El tancament de les negociacions per a 2023 sense la signatura d'AFASCAT converteix l'acord en un \"Acord-conveni extratutari\"<\/strong> que no t\u00e9 una efic\u00e0cia general enfront de tots els subjectes representants en la negociaci\u00f3 i en el seu \u00e0mbit funcional, sin\u00f3 que <strong>obliga, \u00fanicament, a les empreses-oficines de farm\u00e0cia associades a l'AFB i als treballadors afiliats als sindicats signants (UGT, CCEOO i ASATEF).<\/strong><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>No obstant aix\u00f2, legalment, qualsevol treballador del sector pot adherir-se lliurement a aquest acord perqu\u00e8 li sigui aplicat l'augment salarial retroactiu de 2023 (4%) i la resta de condicions contemplades a l'acord,<\/strong> la qual cosa suposa actualitzar autom\u00e0ticament, tamb\u00e9 per 2024, el salari base i altres complements salarials de cada lloc de treball\/nivell professional en el sector.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Podeu consultar els detalls en la circular de l'assessor jur\u00eddic-laboral de l'AFB, Consultor\u00eda y Estudio Legal.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/02\/Documentacio-completa.-1-2.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Descarregar la documentaci\u00f3 (circular, acord signat i full-model d'adhesi\u00f3)<\/a><\/span><\/em><\/strong><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>Jornada explicativa d'aquest acord<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p><strong>L'AFB <\/strong>organitza, el pr\u00f2xim <strong>dilluns, dia 26 de febrer, a les 17.00 hores, <\/strong>una jornada a <strong>Barcelona <\/strong>per explicar als farmac\u00e8utics titulars, siguin socis o no de l'empresarial, en qu\u00e8 consisteix aquest acord per 2023 i resoldre tots els dubtes dels assistents.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Els interessats a assistir poden <strong>resevar pla\u00e7a<\/strong> omplint el<strong><em><a href=\"https:\/\/docs.google.com\/forms\/d\/e\/1FAIpQLSfZko9ufpqC8IIKPJoByMmv9fA_Nr7dWR_7zs_yrDq3IzXKdg\/viewform\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline\"> formulari d'inscripci\u00f3.<\/span><\/a><\/em><\/strong><\/p>\n<!-- \/wp:paragraph -->","_et_gb_content_width":"","footnotes":""},"categories":[2066,10,11,12,13,2264,14,15],"tags":[85,604,1156,1748,2455,2746],"class_list":["post-237726","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-empresarials","category-fefac","category-afb","category-afet","category-articles-periodistics","category-afell","category-agfe","tag-fefac","tag-estudi","tag-farmacies","tag-farmacs","tag-sars-cov-2","tag-csic"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un estudi troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 pel SARS-CoV-2<\/title>\n<meta name=\"description\" content=\"La uni\u00f3 de ribavirina i remdesivir elimina el virus SARS-CoV-2 en induir un exc\u00e9s de mutacions en el seu genoma que li impedeixen multiplicar-se.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un estudi troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 pel SARS-CoV-2\" \/>\n<meta property=\"og:description\" content=\"La uni\u00f3 de ribavirina i remdesivir elimina el virus SARS-CoV-2 en induir un exc\u00e9s de mutacions en el seu genoma que li impedeixen multiplicar-se.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T15:04:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-09T08:55:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/04\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lgallardo@fefac.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lgallardo@fefac.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/\"},\"author\":{\"name\":\"lgallardo@fefac.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\"},\"headline\":\"Un estudi liderat pel CSIC troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 enfront del SARS-CoV-2\",\"datePublished\":\"2024-04-17T15:04:41+00:00\",\"dateModified\":\"2024-05-09T08:55:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/\"},\"wordCount\":246,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg\",\"keywords\":[\"FEFAC\",\"estudi\",\"farm\u00e0cies\",\"f\u00e0rmacs\",\"SARS-CoV-2\",\"CSIC\"],\"articleSection\":[\"Actualitat\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"Recull de premsa Covid-19\",\"AFELL\",\"AGFE\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/\",\"name\":\"Un estudi troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 pel SARS-CoV-2\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg\",\"datePublished\":\"2024-04-17T15:04:41+00:00\",\"dateModified\":\"2024-05-09T08:55:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\"},\"description\":\"La uni\u00f3 de ribavirina i remdesivir elimina el virus SARS-CoV-2 en induir un exc\u00e9s de mutacions en el seu genoma que li impedeixen multiplicar-se.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg\",\"width\":800,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un estudi liderat pel CSIC troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 enfront del SARS-CoV-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\",\"name\":\"lgallardo@fefac.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/lucia-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un estudi troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 pel SARS-CoV-2","description":"La uni\u00f3 de ribavirina i remdesivir elimina el virus SARS-CoV-2 en induir un exc\u00e9s de mutacions en el seu genoma que li impedeixen multiplicar-se.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/","og_locale":"ca_ES","og_type":"article","og_title":"Un estudi troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 pel SARS-CoV-2","og_description":"La uni\u00f3 de ribavirina i remdesivir elimina el virus SARS-CoV-2 en induir un exc\u00e9s de mutacions en el seu genoma que li impedeixen multiplicar-se.","og_url":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/","og_site_name":"FEFAC","article_published_time":"2024-04-17T15:04:41+00:00","article_modified_time":"2024-05-09T08:55:33+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/04\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg","type":"image\/jpeg"}],"author":"lgallardo@fefac.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lgallardo@fefac.cat","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/"},"author":{"name":"lgallardo@fefac.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9"},"headline":"Un estudi liderat pel CSIC troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 enfront del SARS-CoV-2","datePublished":"2024-04-17T15:04:41+00:00","dateModified":"2024-05-09T08:55:33+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/"},"wordCount":246,"commentCount":0,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/04\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg","keywords":["FEFAC","estudi","farm\u00e0cies","f\u00e0rmacs","SARS-CoV-2","CSIC"],"articleSection":["Actualitat","Empresarials","FEFAC","AFB","AFET","Recull de premsa Covid-19","AFELL","AGFE"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/","url":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/","name":"Un estudi troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 pel SARS-CoV-2","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/04\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg","datePublished":"2024-04-17T15:04:41+00:00","dateModified":"2024-05-09T08:55:33+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9"},"description":"La uni\u00f3 de ribavirina i remdesivir elimina el virus SARS-CoV-2 en induir un exc\u00e9s de mutacions en el seu genoma que li impedeixen multiplicar-se.","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/04\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/04\/Foto-A.I.-de-Avila-P3_Br-J-Pharmacol_.jpg","width":800,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/estudi-liderat-csic-troba-combinacio-farmacs-eficac-enfront-sars-cov-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Un estudi liderat pel CSIC troba una combinaci\u00f3 de f\u00e0rmacs efica\u00e7 enfront del SARS-CoV-2"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9","name":"lgallardo@fefac.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/lucia-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=237726"}],"version-history":[{"count":3,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237726\/revisions"}],"predecessor-version":[{"id":237736,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237726\/revisions\/237736"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/237729"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=237726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=237726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=237726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}